Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Aqualex Co., Ltd.
WARNING LETTER
•Aqualex Co., Ltd.•October 20, 2023

Aqualex Co., Ltd. – FDA Warning Letter, Oct 20, 2023

Record Details

On June 12, 2024, the FDA issued a Warning Letter to Aqualex Co., Ltd. following an inspection from October 16-20, 2023, citing significant Current Good Manufacturing Practice (CGMP) violations for finished pharmaceuticals, rendering their drug products adulterated. The product "DBH Beverly Hills, EGF FGF DNA, UV Shield" was also identified as an unapproved new drug and misbranded.

Key violations include: 1. **Failure to establish adequate written procedures for production and process control (21 CFR 211.100(a))**: The firm lacked data to validate manufacturing processes and qualify equipment for OTC SPF sunscreen. Their response was inadequate, failing to assess the impact on distributed products or provide detailed plans. 2. **Failure to use appropriately designed equipment (21 CFR 211.63)**: The firm's water system for drug product formulation had stagnant water points (dead-legs), fostering biofilm development. The response was inadequate, not demonstrating proper design, control, or maintenance. 3. **Quality control unit failure (21 CFR 211.22)**: The Quality Unit failed to ensure adequate control over CGMP records, with unauthorized changes possible and original records found marked for shredding. Laboratory data was routinely recorded on temporary records and discarded. The firm's response lacked sufficient detail on record management and impact assessment.

Company
Aqualex Co., Ltd.
Inspection date
October 20, 2023
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Francis Godwin (Director)
  • Frank Wackes (Investigator)
  • Ann Lee
View Company Profile

ID · d8ba605a-2f7b-49d4-9fa4-ffcf972fc776

Violation Codes10
21 CFR 21021 CFR 21121 CFR 211.100(a)21 CFR 211.6321 CFR 211.2221 CFR 211.165(b)21 CFR 211.166(a)FD&C Act 501(a)(2)(B)21.U.S.C. 355(a)21 U.S.C. 352(a)

Full citation text and observation details available on the Dashboard.

Other documents for Aqualex Co., Ltd.
  • 483 - 2023-10-20October 20, 2023

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Aqualex Co., Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.